DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS

NIH RePORTER · NIH · N01 · $6,457,269 · view on reporter.nih.gov ↗

Abstract

The Division of Cancer Treatment and Diagnosis, NCI is requesting support for the development and production of canine-specific agonists and/or antagonist antibodies to support immunotherapy studies in companion canines

Key facts

NIH application ID: 10502671
Project number: 75N91019D00024-0-759102100016-1
Recipient: LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator: VICKIE COLEMAN
Activity code: N01
Funding institute: NIH
Fiscal year: 2021
Award amount: $6,457,269
Award type: —
Project period: 2021-09-16 → 2025-09-15